Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and-or Fibroblast Growth Factor-2Reportar como inadecuado

Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and-or Fibroblast Growth Factor-2 - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Periodontal ligament stem cells PDLSCs represent a good source of multipotent cells for cell-based therapies in regenerative medicine. The success rate of these treatments is severely dependent on the establishment of adequate vasculature in order to provide oxygen and nutrients to the transplanted cells. Pharmacological preconditioning of stem cells has been proposed as a promising method to augment their therapeutic efficacy. In this study, the aim was to improve the intrinsic angiogenic properties of PDLSCs by in vitro pretreatment with deferoxamine DFX; 100μM, fibroblast growth factor-2 FGF-2; 10ng-mL or both substances combined. An antibody array revealed the differential expression of several proteins, including vascular endothelial growth factor VEGF and placental growth factor PlGF. ELISA data confirmed a 1.5 to 1.8-fold increase in VEGF for all tested conditions. Moreover, 48 hours after the removal of DFX, VEGF levels remained elevated 1.8-fold compared to control conditions. FGF-2 and combination treatment resulted in a 5.4 to 13.1-fold increase in PlGF secretion, whereas DFX treatment had no effect. Furthermore, both PDLSCs as pretreated PDLSCs induced endothelial migration. Despite the significant elevated VEGF levels of pretreated PDLSCs, the induced endothelial migration was not higher by pretreated PDLSCs. We find that the observed induced endothelial cell motility was not dependent on VEGF, since blocking the VEGFR1-3 with Axitinib 0.5nM did not inhibit endothelial motility towards PDLSCs. Taken together, this study provides evidence that preconditioning with DFX and-or FGF-2 significantly improves the angiogenic secretome of PDLSCs, in particular VEGF and PlGF secretion. However, our data suggest that VEGF is not the only player when it comes to influencing endothelial behavior by the PDLSCs.

Autor: Jessica Ratajczak, Petra Hilkens, Pascal Gervois, Esther Wolfs, Reinhilde Jacobs, Ivo Lambrichts, Annelies Bronckaers



Documentos relacionados